Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
USANA Probiotic is a dietary supplement developed and marketed by USANA Health Sciences, designed to support gastrointestinal health and immune function. The product features a 50/50 blend of two extensively studied probiotic bacterial strains: *Lactobacillus rhamnosus* LGG and *Bifidobacterium animalis* subsp. *lactis* BB-12. Each serving delivers 12 billion colony-forming units (CFUs) of live bacteria, supplemented with the prebiotic fiber inulin to promote the growth and colonization of beneficial gut microflora. Formulated as a shelf-stable powder in stick packs, USANA Probiotic is intended to help balance the gut microbiome and alleviate common digestive issues such as bloating, gas, and irregular bowel movements. It is dairy-free, sugar-free, and gluten-free, and has received quality verification seals from ConsumerLab.com.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on USANA Probiotic.